tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

Oncolytics promotes John McAdory to COO
The FlyOncolytics promotes John McAdory to COO
2d ago
CGON
ONCY
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
PremiumRatings
Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
8d ago
CGON
CG Oncology announces departure of president, COO Ambaw Bellete
PremiumThe Fly
CG Oncology announces departure of president, COO Ambaw Bellete
9d ago
CGON
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
PremiumThe Fly
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
9d ago
CGON
CG Oncology Reshapes Executive Team Amid Leadership Transition
PremiumCompany Announcements
CG Oncology Reshapes Executive Team Amid Leadership Transition
9d ago
8K
CGON
CG Oncology initiated with a Peer Perform at Wolfe Research
PremiumThe FlyCG Oncology initiated with a Peer Perform at Wolfe Research
16d ago
CGON
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
17d ago
CGON
CG Oncology reports first results from CORE-008 Cohort CX
Premium
The Fly
CG Oncology reports first results from CORE-008 Cohort CX
20d ago
CGON
CG Oncology price target raised to $82 from $77 at Truist
PremiumThe Fly
CG Oncology price target raised to $82 from $77 at Truist
21d ago
CGON
CG Oncology price target raised to $81 from $79 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $81 from $79 at RBC Capital
23d ago
CGON
CG Oncology price target raised to $80 from $77 at Wedbush
PremiumThe Fly
CG Oncology price target raised to $80 from $77 at Wedbush
24d ago
CGON
CG Oncology price target raised to $96 from $91 at JPMorgan
PremiumThe Fly
CG Oncology price target raised to $96 from $91 at JPMorgan
24d ago
CGON
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
PremiumRatingsCG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
24d ago
CGON
CG Oncology price target lowered to $83 from $84 at BofA
Premium
The Fly
CG Oncology price target lowered to $83 from $84 at BofA
25d ago
CGON
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
Premium
Ratings
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
25d ago
CGON
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
PremiumRatings
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
25d ago
CGON
CG Oncology reports Q1 EPS (71c), consensus (54c)
PremiumThe Fly
CG Oncology reports Q1 EPS (71c), consensus (54c)
27d ago
CGON
CG Oncology price target raised to $79 from $73 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $79 from $73 at RBC Capital
1M ago
CGON
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
CGON
SMMT
JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
PremiumThe FlyJPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
2M ago
JNJ
CGON
CG Oncology price target raised to $84 from $72 at BofA
Premium
The Fly
CG Oncology price target raised to $84 from $72 at BofA
2M ago
CGON
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
Premium
Company Announcements
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
2M ago
8K
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >